[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
April 2002

Topical 0.1% Alitretinoin Gel for Classic Kaposi Sarcoma

Author Affiliations

Not Available

Arch Dermatol. 2002;138(4):542-543. doi:10.1001/archderm.138.4.533

Alitretinoin topical gel (Panretin gel; Ligand Pharmaceuticals Inc, San Diego, Calif) is effective and well tolerated for the treatment of cutaneous lesions in patients with acquired immunodeficiency syndrome–related Kaposi sarcoma (KS),14 offering patients a self-administered, noninvasive, topical alternative treatment. To my knowledge, effective treatment of classic KS with this formulation has not been described.

First Page Preview View Large
First page PDF preview
First page PDF preview